Interview: Kyrexa launches £1.5m funding round for revolutionary Rimcazole canine cancer treatment

0
7

Interview: Kyrexa launches £1.5m funding round for revolutionary Rimcazole canine cancer treatment

Dr Clare Knottenbelt, CEO of Kyrexa, discusses how the company is advancing canine cancer treatment with Rimcazole.

The post Interview: Kyrexa launches £1.5m funding round for revolutionary Rimcazole canine cancer treatment appeared first on Innovation News Network.

Jack Thomas


Quero saber mais sobre como ter sucesso no mundo digital